Medical Marijuana, Inc. (OTC: MJNA)

Medical Marijuana, Inc. (OTC: MJNA)

posted in: client-profiles by On December 26th, 2013

Tags: , ,

Medical Marijuana, Inc. (OTC: MJNA)


Medical Marijuana Inc. (“MJNA”) is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company comprises a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.

These products range from patented and proprietary based cannabinoid products, to seed and stalk or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.

The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 85 proprietary and patented cannabinoid “delivery methods” that are more “socially and medically acceptable” than typical industry methods. Finally, MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking, production and standardization methods for the medicinal herb industry.

Medical Marijuana Inc.’s patented and proprietary technologies include the only pharmaceutical grade vertical Bio-Technology Company specializing in the standardization, production and extraction of phyto-cannabinoids. MJNA’s PhytoSPHERE Systems and their advanced plant growth technologies save significantly on resources necessary for production of medical grade cannabis. In addition to providing a medical grade end product, extracts and compounds, PhytoSPHERE Systems also includes pre-and-post production tracking, gemplasm references, packaging and processing to ensure consistency and genetic purity.


MJNA’s mission is to be the premier cannabis and hemp industry innovators, leveraging it’s team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. MJNA strives to create awareness within the industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.


Medical Marijuana Inc. continues to expand its ever growing portfolio of innovative businesses. Our newest partnership with Kannalife Sciences lends a perfect fit for the Medical Marijuana Inc., family of companies. In addition to Kannalife’s years in the development of standardization in packaging cannabis based products the company was recently awarded an Exclusive License Agreement With National Institutes of Health – Office of Technology Transfer (“NIH-OTT”) for the Commercialization of U.S. Patent 6,630,507, “Cannabinoids as Antioxidants and Neuroprotectants” (the “’507 Patent”).
To Learn more visit


 CanChew GumCanChew BiotechnologiesCanipa HoldingsHempMedsRXKannaLifeRed Dice Holdings

PhytoSPHERE SystemsWellness Managed Services


The Medical Marijuana Inc. (MJNA) team is made up of a diverse group of highly skilled professionals in their respected fields. Each individual who makes up the corporate structure of MJNA plays an integral part of the company’s day to day operation and overall success. MJNA believes for a company to not merely succeed but thrive in any economic and political environment you must first have the right people on the team, make sure they are in the right position, and allow them to operate with integrity and an entrepreneurial spirit.

The MJNA executive team work with industry and world authorities on cannabinoid based science and technologies to source, evaluate, acquire and develop value added companies and products. Each of the entities that make Medical Marijuana Inc.’s structure has a clearly defined purpose as it relates to an individual market, consumer or partner need. By utilizing these different facets, MJNA is able to provide an unparalleled platform of businesses that are unique among industry competitors. The professionals at MJNA are dedicated to “keeping it simple”. In an industry that has ever changing economic, political and scientific climate, its MJNA’s team’s ability to do just that that sets it apart.

Board of Directors

Michelle Sides

Michael D. Julian

Executive Management

Michelle Sides
Chief Operating Officer

Tripp Keber
President, RDH Licensing

Chuck Smith
Chief Operating Officer, RDH

Dr. Philip A. Van Damme
Chief Medical Officer, CanChew Biotechnologies
Director, Canchew Biotechnologies

Dr. George E. Anastassov
Chief Executive Officer, CanChew Biotechnologies
Director, Canchew Biotechnologies

Lekhram Changoer
Chief Technology Officer, CanChew Biotechnologies
Director, Canchew Biotechnologies

Advisory Committees – Medical Committee

Dr. Philip A. Van Damme

Dr. George E. Anastassov

Comments are closed.